First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
2018 · New England Journal of Medicine · 3,395 citations
https://doi.org/10.1056/nejmoa1809064
A
Aleksandra Szczęsna
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
12.0K
Citations
31
h-index
47
i10-index
Aleksandra Szczęsna is an academic researcher from Centrum Leczenia Oparzeń. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 31, co-authored 90 publications.
Papers by this author
worksNecitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
2015 · The Lancet Oncology · 472 citations
https://doi.org/10.1016/s1470-2045(15)00021-2
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial
2020 · British Journal of Cancer · 67 citations
https://doi.org/10.1038/s41416-020-0785-y
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer
2006 · British Journal of Cancer · 28 citations
https://doi.org/10.1038/sj.bjc.6603115
Pregnant surgeon — assessment of potential harm to the woman and her unborn child
2019 · Ginekologia Polska · 7 citations
https://doi.org/10.5603/gp.2019.0081
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat